| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |